一例因慢性鼻炎接受生物治疗的患者感染播散性阿米巴病的罕见病例。

IF 7.2 2区医学 Q1 OTORHINOLARYNGOLOGY

International Forum of Allergy & Rhinology Pub Date : 2024-10-23 DOI:10.1002/alr.23473

Ariel Omiunu, Lindsey Brown, Darpan Kayastha, R Peter Manes

引用次数: 0

摘要

要点杜匹鲁单抗以Th2相关炎症介质为靶点，可减轻CRSwNP的疾病负担。虽然罕见，但潜在的后遗症包括病毒、蠕虫和潜在的阿米巴感染。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

A rare case of disseminated amebiasis in a patient on biologic therapy for chronic rhinosinusitis.

Key points: Dupilumab targets Th2-associated inflammatory mediators to reduce disease burden in CRSwNP. While rare, potential sequelae include viral, helminth, and potentially amebic infections.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

International Forum of Allergy & Rhinology OTORHINOLARYNGOLOGY-

CiteScore

11.70

自引率

10.90%

发文量

185

审稿时长

6-12 weeks

期刊介绍： International Forum of Allergy & Rhinologyis a peer-reviewed scientific journal, and the Official Journal of the American Rhinologic Society and the American Academy of Otolaryngic Allergy. International Forum of Allergy Rhinology provides a forum for clinical researchers, basic scientists, clinicians, and others to publish original research and explore controversies in the medical and surgical treatment of patients with otolaryngic allergy, rhinologic, and skull base conditions. The application of current research to the management of otolaryngic allergy, rhinologic, and skull base diseases and the need for further investigation will be highlighted.